Detalles de la búsqueda
1.
Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2-18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study.
Lancet Infect Dis;
22(9): 1303-1312, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717995
2.
Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants.
Sci Rep;
12(1): 12038, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35835822
3.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.
Lancet Infect Dis;
21(5): 637-646, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33485468
4.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial.
Lancet Infect Dis;
21(7): 950-961, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33705727
5.
Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation.
iScience;
24(4): 102298, 2021 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33723528
Resultados
1 -
5
de 5
1
Próxima >
>>